Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease

Neurobiology of Aging

Volumn 25, Issue 2, 2004, Pages 141-147

  Hoskin, Elena K ^a,b   Tang, Ming X ^b,c   Manly, Jennifer J ^a   Mayeux, Richard ^a,b,c,d  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NONE   (United States)

Author keywords

Aging; Alzheimer's disease; Dementia; Estrogen; Hormones

Indexed keywords

ESTRADIOL; ESTRONE; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGE DISTRIBUTION; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; ETHNOLOGY; FEMALE; FOLLITROPIN BLOOD LEVEL; GEOGRAPHY; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICARE; MENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; UNITED STATES;

EID: 1642512469     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00046-0     Document Type: Article

References (54)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (DSM-IV). Washington, DC: American Psychiatric Association; 1994. p. 143-7.
2. Asthana S., Craft S., Baker L.D.et al. Cognitive and neuroendocrine responses to transdermal estrogen in postmenopausal women with Alzheimer's disease. Psychoendocrinology. 24:1999;522-529.
3. Barrett-Connor E., Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. J. Am. Geriatr. Soc. 47(11):1999;1289-1293.
4. Barrett-Connor E., Goodman-Gruen D., Patay B. Endogenous sex hormones and cognitive function in older men. J. Clin. Endocrinol. Metab. 84(10):1999;3681-3685.
5. Bolelli G., Muti P., Micheli A.et al. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormone in serum and plasma. Cancer Epidemiol. Biomarkers Prev. 4:1995;509-513.
6. Brenner D.E., Kukull W.A., Stergachis A.et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol. 140:1994;262-267.
7. Bureau C. Census of population and housing: summary tape file 1; technical documentation. Washington, DC; 1991.
8. Caldwell JD, Hofle S, Englof I. Sex hormone binding globulin facilitates female sexual receptivity except when coupled to dihydrotestosterone. Brain Res 2002;6,948(1/2):102-7.
9. Campagnoli C., Biglia N., Altare F., Lanza M.G., Lesca L.et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex-hormone binding globulin serum levels. Gynecol. Endocrinol. 7(4):1993;251-258.
10. Cauley J.A., Gutai J.P., Kuller L.H., LeDonne D., Powell J.G. The epidemiology of serum sex hormones in postmenopausal women. Am. J. Epidemiol. 129(6):1989;1120-1131.
11. Cunningham C.J., Sinnott M., Denihan A.et al. Endogenous sex hormone levels in postmenopausal women with Alzheimer's disease. J. Clin. Endocrinol. Metab. 86(3):2001;1099-1103.
12. Drake E.B., Henderson V.W., Stanczyk F.Z.et al. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology. 54(3):2000;599-603.
13. Fillenbaum G.G., Hanlon J.T., Landerman L.R., Schmader K.E. Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. Am. J. Epidemiol. 153(2):2001;137-144.
14. Gelmacher D.S., Whitehouse P.J. Evaluation of dementia. N. Eng. J. Med. 335:1996;330.
15. Greenfield J.P., Leung L.W., Cai D.et al. Estrogen lowers Alzheimer β-amyloid generation by stimulating trans-golgi network vesicle biogenesis. J. Biol. Chem. 277:2002;12128-12136.
16. Hammond G. Potential functions of plasma steroid-binding proteins. Trends Endocrinol. Metab. 6(9/10):1995;298-304.
17. Hampl R., Starka L. Sex hormone-binding globulin in endocrine regulation (minireview). Endocr. Regul. 30(2):1996;57-65.
18. Hemsell D.L., Grodin J.M., Brenner P.F., Siiteri P.K., MacDonald P.C. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J. Clin. Endocrinol. Metab. 38(3):1974;476-479.
19. Hogervorst E., Smith D. The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuroendocrinol. Lett. 23(2):2002;155-160.
20. Jacobs D.M., Tang M.X., Stern Y.et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 50(2):1998;368-373.
21. Jaffe A.B., Toran-Allerand C.D., Greengard P., Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269(18):1994;13065-13068.
22. Judd H.L., Shamonki I.M., Frumar A.M., Lagasse L.D. Origin of serum estradiol in postmenopausal women. Obstet. Gynecol. 59(6):1982;680-686.
23. Kampen D.L., Sherwin B.B. Estrogen use and verbal memory in healthy postmenopausal women. Obstet. Gynecol. 83(6):1994;979-983.
24. Kawas C., Resnick S., Morrison A.et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 48:1997;1517-1521.
25. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basic forebrain nuclei and projection areas of female rats. Exp. Neurol. 89:1985;484-490.
26. Manly J.J., Merchant C.A., Jacobs D.M.et al. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology. 54(4):2000;833-837.
27. Matthews K., Cauley J., Yaffe K., Zmuda J.M. Estrogen replacement therapy and cognitive decline in older community women. J. Am. Geriatr. Soc. 47(5):1999;518-523.
28. Mayeux R., Stern Y., Ottman R.et al. The apolipoprotein ε4 allele in patient's with Alzheimer's disease. Ann. Neurol. 34:1993;752-754.
29. McEwen B.S., Alves S.E., Bulloch K., Weiland N.G. Ovarian steroids and the brain: implications for cognition and aging. Neurology. 48(5 Suppl 7):1997;S8-S15.
30. Meldrum D.R., Davidson B.J., Tataryn I.V., Judd H.L. Changes in circulating steroids with aging in postmenopausal women. Obstet. Gynecol. 57:1981;624-628.
31. NIH. Clinical guidelines on the identification of obesity in adults; 2001. Available at: http://www.nih.gov .
32. O'Connell M.B. Pharmacokinetic and pharmacologic variation between different estrogen products. J. Clin. Pharmacol. 25:1995;18S-24S.
33. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer's disease. Arch. Int. Med. 156:1996;2213-2217.
34. Papasozomenos S.Ch., Shanavas A. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 99(3):2002;1140-1145.
35. Pardridge W.M., Mietus L.J., Frumar A.M., Davidson B.J., Judd H.L. Effects of human serum on transport of testosterone and estradiol into rat brain. Am. J. Physiol. 239(1):1980;E103-E108.
36. Pike C. Testosterone attenuates β-amyloid toxicity in cultured hippocampal neurons. Brain Res. 919:2001;160-165.
37. Rasmuson S., Nasman B., Carlstrom K.et al. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 13(2):2002;74-79.
38. Schupf N, Pang D, Patel B, et al. Onset of dementia is associated with age at menopause in women with Down syndrome, in press.
39. Senanarong V., Vannasaeng S., Poungvarin N.et al. Endogenous estradiol in elderly individuals: cognitive and noncognitive associations. Arch. Neurol. 59(3):2002;385-389.
40. Short R.A., Bowen R.L., O'Brien P.C.et al. Elevated gonadotropin levels in patients with Alzheimer's disease. Mayo Clin. Proc. 76(9):2001;906-909.
41. Siiteri P.K., Murai J.T., Hammond G.L., Nisker J.A., Raymoure W.J., Kuhn R.W. The serum transport of steroid hormones. Recent Prog. Horm. Res. 38:1982;457-510.
42. Skalba P., Korfanty A., Mroczka W.et al. Changes of SHBG concentrations in postmenopausal women. Ginekol. Pol. 72(12A):2001;1388-1392.
43. Stern Y., Andrews H., Pittman J.et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch. Neurol. 49(5):1992;453-460.
44. Stomati M., Hartmann B., Spinetti A.et al. Effects of hormonal replacement therapy on plasma sex hormone binding globulin, androgen, and insulin-like growth factor-1 levels in postmenopausal women. J. Endocrinol. Invest. 19(8):1996;535-541.
45. Tang M.X., Stern Y., Marder K.et al. The APOE-epsilon4 allele and the risk of Alzheimer's disease among African Americans, Whites, and Hispanics. JAMA. 279(10):1998;751-755.
46. Tang M.X., Jacobs D., Stern Y.et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348(9025):1996;429-432.
47. Tang M.X., Maestre G., Tsai W.-Y.et al. Relative risk of Alzheimer's disease and age-at-onset base of APOE genotypes among elderly African Americans, Caucasians and Hispanics in New York City. Am. J. Hum. Genet. 58:1996;554-574.
48. Toran-Allerand C.D., Miranda R.C., Bentham W.D.et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4668-4672.
49. Twist S.J., Taylor G.A., Weddell A., Weightman D.R., Edwardson J.A., Morris C.M. Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci. Lett. 286(1):2000;1-4.
50. Waring S.C., Rocca W.A., Petersen R.C.et al. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology. 52:1999;965-970.
51. Woolley C.S., McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336(2):1993;293-306.
52. World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva, Switzerland: World Health Organization; 1993. p. 36-40.
53. Xu H., Gouras G.K., Greenfield J.P.et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4:1998;447-451.
54. Yaffe K., Lui L.Y., Zmuda J.et al. Sex hormones and cognitive function in older men. J. Am. Geriatr. Soc. 50(4):2002;707-712.